We modified a genetically engineered chronic pancreatitis (CP) model by inserting the p.D23A mutation into exon 2 of the trypsinogen 7 precursor and demonstrated that overexpression of Hspb1 blocked the development of CP. This evidence concerns the gene HSPB1 and chronic pancreatitis.